Global Intragastric Balloon Market Size Study & Forecast, by Product Type (Single, Dual, and Triple), By Administration (Pill and Endoscopy), By Filling Material (Saline-Filled and Gas-Filled), By End-user (Hospitals & Clinics, Outpatient Surgical Centers

Global Intragastric Balloon Market Size Study & Forecast, by Product Type (Single, Dual, and Triple), By Administration (Pill and Endoscopy), By Filling Material (Saline-Filled and Gas-Filled), By End-user (Hospitals & Clinics, Outpatient Surgical Centers, and Others), and Regional Analysis, 2023-2030

Global Intragastric Balloon Market is valued at approximately USD 39.2 million in 2022 and is anticipated to grow with a healthy growth rate of more than 13.9% over the forecast period 2023-2030. The intragastric balloon is a medical device designed to aid in weight loss for individuals struggling with obesity. It is a soft silicone balloon inserted into the stomach through the mouth and filled with a sterile saline solution, creating a sensation of fullness, and reducing food intake. The procedure is minimally invasive and temporarily administered endoscopically. Also, the balloon encourages healthier eating habits and lifestyle changes, serving as a supportive measure under healthcare supervision. The rise in adoption of minimally invasive treatment, increasing approval for intragastric balloon, and soaring healthcare expenditure are the most prominent factors that are propelling the market demand across the globe. According to a study published by the National Center for Biotechnology Information (NCBI) in January 2023, intragastric balloons emerge as a minimally invasive solution in addressing the obesity crisis. The United States and European markets have approved multiple intragastric balloons, with criteria varying from a BMI of 30 to 35 kg/m^2 in the U.S. to 27 to 35 kg/m^2 in Europe.

In addition, the demand for intragastric balloon placement is rising due to its safety and cost-effectiveness compared to surgical alternatives. According tothe World Health Organization's (WHO),as of 2022, the global prevalence of obesity has reached concerning levels, with approximately 1 in 8 individuals worldwide living with obesity. The rates of adult obesity have more than doubled since 1990, while adolescent obesity has quadrupled during the same period. Among adults aged 18 years and older, around 2.5 billion were classified as overweight, with a staggering 890 million falling into the category of obesity. This represents 43% of adults being overweight and 16% living with obesity. Moreover, there were 37 million overweight children under the age of 5, and over 390 million children and adolescents aged 5–19 years were overweight, including 160 million who were living with obesity. These statistics highlight the urgent need for global efforts to address and combat the obesity epidemic across age groups.. Intragastric balloons are extensively utilized for obesity treatment, delivering effective outcomes. Accordingly, the rise in prevalence of obesity globally is anticipated to positively influence the market growth. Obesity is associated with various non-communicable diseases like cardiovascular diseases, diabetes, stroke, hypertension, and certain cancers, prompting governments worldwide to raise awareness about obesity management. This awareness campaign is expected to fuel the adoption of intragastric balloons. Moreover, the rise the advancements in balloon technology, as well as the growing emphasis on lifestyle-focused weight management presents various lucrative opportunities over the forecasting years. However, the complications and risks related to intragastric balloon procedure, along with the lack of reimbursement are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Intragastric Balloon Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the widespread prevalence of obesity, the presence of skilled professionals, and significant adoption of weight loss treatments. Additionally, the rising popularity and adoption of the intragastric balloon further bolster regional growth Whereas Asia Pacific is expected to grow at the highest CAGR over the forecast years. The expanding patient population, growing awareness among healthcare professionals and patients regarding new technologies, and the introduction of various weight loss programs are significantly propelling the market demand across the region. For instance. in July 2020, Allurion Technologies, Inc. announced that the company has extended its presence in Asia through the introduction of the Elipse- a Gastric Balloon weight loss program.

Major market players included in this report are:
Allurion Technologies, Inc. (U.S.)
Apollo Endosurgery Inc. (U.S.)
ReShape Lifesciences, Inc. (U.S.)
Spatz Medical (U.S.)
Lexel SRL (Argentina)
Medispar NV (Belgium)
Endalis (France)
Districlass Medical (France)
Silimed Brazil (Brazil)
Suzhou Shenyun Medical Equipment Co., Ltd (China)

Recent Developments in the Market:
 In October 2023, Allurion achieved full patient enrollment for its AUDACITY trial. This pivotal study is specifically structured to endorse the U.S. FDA approval process for the gastric balloon developed by the company.
 In September 2023, ReShape Lifesciences, Inc. initiated a royalty-bearing license agreement with Biorad Medisys, Pvt. Ltd. (Biorad) for the development, commercialization, and distribution of Obalon gastric balloons across Pakistan, India, Nepal, Sri Lanka, and other Asia Pacific countries. This strategic initiative aims to enhance the company's footprint in emerging markets.
 In June 2023, Allurion announced the company’s collaboration with Medtronic to expand its AI-powered weight loss program into Central and Eastern Europe and the Middle East & Africa (CEMA) regions. This initiative integrates the Allurion balloon procedure-less gastric balloon for weight loss with the Allurion Virtual Care Suite, offering a comprehensive solution for individuals seeking effective weight management.

Global Intragastric Balloon Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered - Product Type, Administration, Filling Material, End-user, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product Type:
Single
Dual
Triple

By Administration:
Pill
Endoscopy

By Filling Material:
Saline-Filled
Gas-Filled

By End-user:
Hospitals & Clinics
Outpatient Surgical Centers
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.